Michael Terrin
Main Profile
Michael L Terrin M.D.C.M., M.P.H. |
|
Principal Investigator, NHLBI Progenitor Cell Biology Consortium Administrative Coordinating Center
|
| Academic Title: Professor |
| Primary Appointment: Epidemiology & Public Health |
| Secondary Appointments: Medicine |
| mterrin@som.umaryland.edu |
| Location: HH, 200 |
| Phone: (410) 706-6139 |
|
Fax: (410) 706-4400 |
Personal History: Education Faculty Appointments Hospital Appointments Research Interests:Clinical Trials; Pulmonary Disease; Cardiovascular Epidemiology; Data Coordinating Centers Current Grant Support:Active Research 1 U24 HL134763-01 (Terrin/Viscardi) 9/20/16-5/31/23 NHLBI Role: PI Progenitor Cell Translational Consortium Administrative Coordinating Center The NHLBI Progenitor Cell Translational Consortium (PCTC) Administrative Coordinating Center has the operational areas: 1) to organize interactions and facilitate collaborations between PCTC investigators, 2) to oversee programs using set-aside funds to stimulate collaborative research and skills development, 3) to share PCTC-generated data and reagents among PCTC investigators and with the research community, and 4) to facilitate access to expertise for preparation of U.S. Food and Drug Administration (FDA) IND and IDE applications. R01 AG037120 (Terrin/Baxter/Matsumura) 8/15/11-7/31/16 (midcourse NCE) NIA Role: PI (multiple) Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA3CT) The primary aim of this multi-site clinical trial is to determine if doxycycline (100mg bid) will inhibit by at least 40% the increase in greatest transverse diameter of small abdominal aortic aneurysms over a 24-month period of observation in comparison to a placebo-treated control group. U01 HL099997 (Terrin) 09/30/09-04/30/16 NHLBI Role: PI Progenitor Cell Biology Consortium Administrative Coordinating Center The Progenitor Cell Biology Consortium Administrative Coordinating Center makes available to the public reports on the research accomplishments of the Consortium, to the general scientific community reports and data from the Consortium, and to the members of the Consortium data and meta-data from each other’s work. The exchange of this information is expected to result in new therapeutic approaches that could shift paradigms and enormously improve outcomes of some of the most frequently fatal diseases in the U.S.; coronary artery disease and emphysema are just two examples. P30 AG028747 (Goldberg/Magaziner) 07/01/11- 06/30/16 NIA Role: Co-Investigator Claude D. Pepper Older Americans Independence Center (OAIC) The mission is to conduct exercise and motor learning based rehabilitation research to optimize the recovery of older adults who have suffered a stroke, hip fracture or other chronic debilitating disease. R01 AG035009 (Magaziner) 09/01/10-08/31/16 (midcourse NCE) NIA Role: Co-Investigator Community Ambulation Following Hip Fracture This randomized controlled multi-center study will evaluate the effect of a 4 month, home delivered multi-component intervention on survival and the ability to ambulate independently in the community among older men and women who have sustained a hip fracture. R01 HD067126 (Viscardi) 03/01/11-02/29/16 NICHD Role: PI (multiple) Azithromycin to prevent BPD in Ureaplasma-infected Preterms This study will 1) evaluate the safety of and how the body processes the antibiotic azithromycin, 2) determine the effectiveness of a 3-day course of azithromycin in eliminating Ureaplasma infection from the lungs of preterm infants, and 3) compare the lung health outcomes of the infants treated with azithromycin with the outcomes of placebo-treated infants.
T32 AG000262 (Magaziner/Baumgarten) 05/01/13-04/30/18 NIA Role: OSC/Faculty Advisor Research Training in the Epidemiology of Aging The objective of this program is to train pre- and post-doctoral students to conduct independent and original research in the epidemiology of aging, with an emphasis on the prevention of late-life disability and functional decline. The program emphasizes four broad substantive areas including: musculoskeletal epidemiology, neuroepidemiology, genetic epidemiology, and the epidemiologic study of long-term care for chronic diseases. 1R21AG050890-01 (Verceles) 08/01/15-05/31/17 NIH Role: OSC/Faculty Advisor Rehabilitation, NMES and High Protein to Reduce Post ICU Syndrome in the Elderly This pilot study will determine whether or not there is evidence of beneficial treatment effects and feasibility of administering neuromuscular electrical stimulation or protein supplementation to elderly, intensive care unit patients to prevent weakness and loss of function experienced as a "Post ICU Syndrome." Dr. Terrin will provide advice on clinical trial design, data collection and data analysis.
Publications:A list of my journal publications may be found at: http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/bibliography/48077438/ |
Copyright ©2016 NHLBI Progenitor Cell Translational Consortium.
